Enzo Biochem, Inc. (NYSE:ENZ) Files An 8-K Other Events
Item 8.01 Other events
On April 17, 2017, Enzo Biochem, Inc. (the Company) issued a
press release titled Enzo Biochems Clinical Laboratory Named an
In-Network Provider to the Fourth Largest National Insurer.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
| 99.1 | Press Release of Enzo Biochem, Inc., dated April 17, 2017. |
About Enzo Biochem, Inc. (NYSE:ENZ)
Enzo Biochem, Inc. is a bioscience company focusing on delivering and applying technology capabilities to produce products and services. The Company’s segments include Enzo Clinical Labs, Enzo Life Sciences and Enzo Therapeutics. Enzo Clinical Labs is a clinical reference laboratory providing a range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. It offers a menu of molecular and other clinical laboratory tests or procedures. Enzo Life Sciences manufactures, develops and markets products and tools to clinical research, drug development and bioscience research customers. Enzo Therapeutics is a biopharmaceutical venture that develops multiple approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases. Its products in the development pipeline include a range of assays for detection of various women’s health infectious agents, as well as for use in the identification of pathogens for other markets. Enzo Biochem, Inc. (NYSE:ENZ) Recent Trading Information
Enzo Biochem, Inc. (NYSE:ENZ) closed its last trading session 00.00 at 7.95 with 309,538 shares trading hands.
